Zheng T - Search Results

1

Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.

Zheng T, Yin D, Lu Z, Wang J, Li Y, Chen X, Liang Y, Song X, Qi S, Sun B, Xie C, Meng X, Pan S, Liu J, Jiang H, Liu L. Zheng T, et al. Mol Cancer. 2014 May 31;13:133. doi: 10.1186/1476-4598-13-133. Mol Cancer. 2014. PMID: 24884809 Free PMC article.

2

Role of microRNA in anticancer drug resistance.

Zheng T, Wang J, Chen X, Liu L. Zheng T, et al. Int J Cancer. 2010 Jan 1;126(1):2-10. doi: 10.1002/ijc.24782. Int J Cancer. 2010. PMID: 19634138 Review.

3

Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways.

Zheng T, Wang J, Song X, Meng X, Pan S, Jiang H, Liu L. Zheng T, et al. J Cancer Res Clin Oncol. 2010 Oct;136(10):1597-604. doi: 10.1007/s00432-010-0817-8. Epub 2010 Feb 20. J Cancer Res Clin Oncol. 2010. PMID: 20174822

4

Disruption of p73-MDM2 binding synergizes with gemcitabine to induce apoptosis in HuCCT1 cholangiocarcinoma cell line with p53 mutation.

Zheng T, Wang J, Chen X, Meng X, Song X, Lu Z, Jiang H, Liu L. Zheng T, et al. Tumour Biol. 2010 Aug;31(4):287-95. doi: 10.1007/s13277-010-0035-7. Epub 2010 Apr 27. Tumour Biol. 2010. PMID: 20422343

5

PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice.

Zheng T, Meng X, Wang J, Chen X, Yin D, Liang Y, Song X, Pan S, Jiang H, Liu L. Zheng T, et al. J Cell Biochem. 2010 Sep 1;111(1):218-28. doi: 10.1002/jcb.22691. J Cell Biochem. 2010. PMID: 20506484

6

microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells.

Meng XZ, Zheng TS, Chen X, Wang JB, Zhang WH, Pan SH, Jiang HC, Liu LX. Meng XZ, et al. J Gastroenterol Hepatol. 2011 Jan;26(1):186-93. doi: 10.1111/j.1440-1746.2010.06317.x. J Gastroenterol Hepatol. 2011. PMID: 21175813

7

Hippo signaling in oval cells and hepatocarcinogenesis.

Zheng T, Wang J, Jiang H, Liu L. Zheng T, et al. Cancer Lett. 2011 Mar 28;302(2):91-9. doi: 10.1016/j.canlet.2010.12.008. Epub 2011 Jan 17. Cancer Lett. 2011. PMID: 21247686 Review.

8

MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.

Wang J, Zheng T, Chen X, Song X, Meng X, Bhatta N, Pan S, Jiang H, Liu L. Wang J, et al. Among authors: zheng t. J Gastroenterol Hepatol. 2011 Feb;26(2):371-7. doi: 10.1111/j.1440-1746.2010.06440.x. J Gastroenterol Hepatol. 2011. PMID: 21261729

9

Regulation of Fertility by the p53 Family Members.

Hu W, Zheng T, Wang J. Hu W, et al. Among authors: zheng t. Genes Cancer. 2011 Apr;2(4):420-30. doi: 10.1177/1947601911408892. Genes Cancer. 2011. PMID: 21779510 Free PMC article.

10

Diphenyl difluoroketone: a potent chemotherapy candidate for human hepatocellular carcinoma.

Liang Y, Yin D, Hou L, Zheng T, Wang J, Meng X, Lu Z, Song X, Pan S, Jiang H, Liu L. Liang Y, et al. Among authors: zheng t. PLoS One. 2011;6(8):e23908. doi: 10.1371/journal.pone.0023908. Epub 2011 Aug 25. PLoS One. 2011. PMID: 21901145 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,475 results

Search Page

Filters